IPO-话题@MedSci

#IPO#

54篇内容 | 1020人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1510859, encodeId=2ec31510859e3, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Bipolar Disord：老年双相情感障碍的双相症状、身体功能受限的研究, objectType=article, longId=729480, objectId=721ee294802a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=721ee294802a, replyNumber=0, likeNumber=44, createdTime=2022-06-15, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=721ee294802a, moduleTitle=Bipolar Disord：老年双相情感障碍的双相症状、身体功能受限的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=721ee294802a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510858, encodeId=c8f1151085854, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Front Aging Neurosci：Lipocalin-2 在卒中后抑郁模型中调节海马小胶质细胞的激活, objectType=article, longId=292462, objectId=7b6d292462c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b6d292462c4, replyNumber=0, likeNumber=51, createdTime=2021-12-23, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b6d292462c4, moduleTitle=Front Aging Neurosci：Lipocalin-2 在卒中后抑郁模型中调节海马小胶质细胞的激活, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b6d292462c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510857, encodeId=e7bc151085e1e, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=J Neuroinflammation：弹性反应增强子结合蛋白通过上调Lipocalin-2促进糖尿病神经炎症和认知损害, objectType=article, longId=221547, objectId=542622154e80, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=542622154e80, replyNumber=0, likeNumber=38, createdTime=2021-12-06, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=542622154e80, moduleTitle=J Neuroinflammation：弹性反应增强子结合蛋白通过上调Lipocalin-2促进糖尿病神经炎症和认知损害, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=542622154e80)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510856, encodeId=07dd1510856da, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=证监会批准同意百济神州科创板IPO注册，拟募资200亿，创历史之最！, objectType=article, longId=220494, objectId=1124220494b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1124220494b7, replyNumber=0, likeNumber=43, createdTime=2021-11-18, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1124220494b7, moduleTitle=证监会批准同意百济神州科创板IPO注册，拟募资200亿，创历史之最！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1124220494b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510855, encodeId=61a0151085519, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=AI领域全球很大IPO开启！医疗产品SenseCare已在国内外医院应用, objectType=article, longId=216427, objectId=ba2921642ede, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba2921642ede, replyNumber=0, likeNumber=41, createdTime=2021-08-30, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba2921642ede, moduleTitle=AI领域全球很大IPO开启！医疗产品SenseCare已在国内外医院应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba2921642ede)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510854, encodeId=f41415108541a, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=助力生物制药关键材料国产化，红杉医疗成员企业纳微科技成功IPO, objectType=article, longId=213102, objectId=02e4213102f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02e4213102f5, replyNumber=0, likeNumber=28, createdTime=2021-06-25, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02e4213102f5, moduleTitle=助力生物制药关键材料国产化，红杉医疗成员企业纳微科技成功IPO, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02e4213102f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510853, encodeId=4924151085325, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=东软医疗递交赴港IPO申请, objectType=article, longId=212206, objectId=91cb212206ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91cb212206ac, replyNumber=0, likeNumber=0, createdTime=2021-06-04, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91cb212206ac, moduleTitle=东软医疗递交赴港IPO申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91cb212206ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510852, encodeId=4400151085257, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Bipolar Disord：卡利拉嗪治疗双相I型抑郁症的疗效和安全性, objectType=article, longId=210952, objectId=cd71210952b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd71210952b8, replyNumber=0, likeNumber=0, createdTime=2021-05-09, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd71210952b8, moduleTitle=Bipolar Disord：卡利拉嗪治疗双相I型抑郁症的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd71210952b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510851, encodeId=b05a151085155, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Self Esteem Brands祝贺Anytime Fitness主加盟商在东京证券交易所成功完成首次公开募股(IPO), objectType=article, longId=204648, objectId=08b22046481b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08b22046481b, replyNumber=0, likeNumber=34, createdTime=2020-12-20, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08b22046481b, moduleTitle=Self Esteem Brands祝贺Anytime Fitness主加盟商在东京证券交易所成功完成首次公开募股(IPO), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08b22046481b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510850, encodeId=61a9151085018, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=临床预测模型建立、验证的报告规范：TRIPOD声明, objectType=article, longId=202890, objectId=058e202890e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=058e202890e7, replyNumber=0, likeNumber=44, createdTime=2020-11-06, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=058e202890e7, moduleTitle=临床预测模型建立、验证的报告规范：TRIPOD声明, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=058e202890e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510849, encodeId=9bfc1510849ee, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=抗艾滋病新药研发公司前沿生物IPO今日上市, objectType=article, longId=202628, objectId=b37720262836, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b37720262836, replyNumber=0, likeNumber=34, createdTime=2020-10-31, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b37720262836, moduleTitle=抗艾滋病新药研发公司前沿生物IPO今日上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b37720262836)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510848, encodeId=4389151084881, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=IPO前夜被收购？Illumina或斥资80亿美元收购Grail, objectType=article, longId=200805, objectId=21c420080513, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21c420080513, replyNumber=0, likeNumber=0, createdTime=2020-09-19, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21c420080513, moduleTitle=IPO前夜被收购？Illumina或斥资80亿美元收购Grail, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21c420080513)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510847, encodeId=3375151084edf, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=肝病研发企业新通药物完成Pre-IPO融资，预计明年在科创板上市, objectType=article, longId=200559, objectId=32db20055902, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32db20055902, replyNumber=0, likeNumber=47, createdTime=2020-09-12, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32db20055902, moduleTitle=肝病研发企业新通药物完成Pre-IPO融资，预计明年在科创板上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32db20055902)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510846, encodeId=75831510846e8, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=J Med Genet：RIPOR2框内缺失是成年人听力损失发病的高频和高发原因, objectType=article, longId=198060, objectId=70ea19806049, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70ea19806049, replyNumber=0, likeNumber=37, createdTime=2020-07-28, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70ea19806049, moduleTitle=J Med Genet：RIPOR2框内缺失是成年人听力损失发病的高频和高发原因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70ea19806049)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510845, encodeId=1d111510845aa, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=燃石医学赴美IPO，加码研发抢跑千亿癌症早检新赛道, objectType=article, longId=194788, objectId=9d33194e8838, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d33194e8838, replyNumber=0, likeNumber=25, createdTime=2020-05-28, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d33194e8838, moduleTitle=燃石医学赴美IPO，加码研发抢跑千亿癌症早检新赛道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d33194e8838)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510844, encodeId=7aac1510844bd, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=J Periodontal Res：晚期糖基化终末产物增加人口腔上皮细胞Lipocalin 2表达, objectType=article, longId=191657, objectId=12a819165ea3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12a819165ea3, replyNumber=0, likeNumber=28, createdTime=2020-04-09, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12a819165ea3, moduleTitle=J Periodontal Res：晚期糖基化终末产物增加人口腔上皮细胞Lipocalin 2表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12a819165ea3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510843, encodeId=381e15108435c, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=2019 IPOG共识建议：先天性胆脂瘤, objectType=article, longId=185224, objectId=9a37185224ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a37185224ce, replyNumber=0, likeNumber=25, createdTime=2019-12-26, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a37185224ce, moduleTitle=2019 IPOG共识建议：先天性胆脂瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a37185224ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510842, encodeId=5631151084235, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=2019 IPOG共识建议：青少年期发作复发性呼吸道乳头状瘤病, objectType=article, longId=183158, objectId=539718315895, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=539718315895, replyNumber=0, likeNumber=0, createdTime=2019-11-19, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=539718315895, moduleTitle=2019 IPOG共识建议：青少年期发作复发性呼吸道乳头状瘤病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=539718315895)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510841, encodeId=7a1f151084100, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=亚盛医药IPO敲定基石投资人，中国生物制药认购1.4亿元, objectType=article, longId=181420, objectId=3c2118142058, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c2118142058, replyNumber=0, likeNumber=30, createdTime=2019-10-18, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c2118142058, moduleTitle=亚盛医药IPO敲定基石投资人，中国生物制药认购1.4亿元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c2118142058)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510840, encodeId=d7e615108405c, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=成立3年赴美IPO却“可能永远无法盈利” 基因编辑还能诱人多久？, objectType=article, longId=181023, objectId=918518102359, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=918518102359, replyNumber=0, likeNumber=41, createdTime=2019-10-14, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=918518102359, moduleTitle=成立3年赴美IPO却“可能永远无法盈利” 基因编辑还能诱人多久？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=918518102359)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IPO

2020-05-29

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

Bipolar Disord：老年双相情感障碍的双相症状、身体功能受限的研究

2022-06-15

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

Front Aging Neurosci：Lipocalin-2 在卒中后抑郁模型中调节海马小胶质细胞的激活

2021-12-23

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

J Neuroinflammation：弹性反应增强子结合蛋白通过上调Lipocalin-2促进糖尿病神经炎症和认知损害

2021-12-06

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

证监会批准同意百济神州科创板IPO注册，拟募资200亿，创历史之最！

2021-11-18

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

AI领域全球很大IPO开启！医疗产品SenseCare已在国内外医院应用

2021-08-30

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

助力生物制药关键材料国产化，红杉医疗成员企业纳微科技成功IPO

2021-06-25

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

东软医疗递交赴港IPO申请

2021-06-04

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

Bipolar Disord：卡利拉嗪治疗双相I型抑郁症的疗效和安全性

2021-05-09

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

Self Esteem Brands祝贺Anytime Fitness主加盟商在东京证券交易所成功完成首次公开募股(IPO)

2020-12-20

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

临床预测模型建立、验证的报告规范：TRIPOD声明

2020-11-06

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

抗艾滋病新药研发公司前沿生物IPO今日上市

2020-10-31

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

IPO前夜被收购？Illumina或斥资80亿美元收购Grail

2020-09-19

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

肝病研发企业新通药物完成Pre-IPO融资，预计明年在科创板上市

2020-09-12

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

J Med Genet：RIPOR2框内缺失是成年人听力损失发病的高频和高发原因

2020-07-28

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

燃石医学赴美IPO，加码研发抢跑千亿癌症早检新赛道

2020-05-28

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

J Periodontal Res：晚期糖基化终末产物增加人口腔上皮细胞Lipocalin 2表达

2020-04-09

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

2019 IPOG共识建议：先天性胆脂瘤

2019-12-26

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

2019 IPOG共识建议：青少年期发作复发性呼吸道乳头状瘤病

2019-11-19

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

亚盛医药IPO敲定基石投资人，中国生物制药认购1.4亿元

2019-10-18

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

成立3年赴美IPO却“可能永远无法盈利” 基因编辑还能诱人多久？

2019-10-14

科室
- - 订阅+
  - 更多科室
工具
服务